Skip to main content

UM SOM Establishes Two Endowed Professorships Through Private Gifts and Matching State Funds

March 10, 2016

University of Maryland School of Medicine (UM SOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that the School has been awarded matching funds from the Maryland Department of Business and Economic Development (DBED) as part of the Maryland E-Nnovation Initiative Fund program. The funds, when combined with private philanthropy, will enable UM SOM to establish two new endowed professorships – one in human virology and vaccine development, the other in surgical science and entrepreneurship.

The E-Nnovation program, which was created as an economic stimulus in 2014, is a special non-lapsing fund designed to help the state’s research universities recruit and retain top scientists and investigators.  Under the fund, $8.5 million will be appropriated by the governor each year from fiscal years 2016 through 2021.

This year, UM SOM secured private donations of nearly $2 million, qualifying the institution for matching state funds. As part of its goal to attract top faculty and foster the development of new technologies and therapies, the School requested that the funds be used to establish the two endowed professorships.

“Endowed professorships provide our outstanding faculty members with the critical resources they need to sustain and expand the promising research they endeavor to carry out, while at the same time enabling them to launch new initiatives to educate and train future physicians, said Dean Reece, who is also Vice President, Medical Affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor. “Professorships are an exceptionally effective tool in retaining and recruiting the best and the brightest.”The first endowed professorship, established with an anonymous gift, will be the Robert C. Gallo Distinguished Professorship, named for Robert C. Gallo, MD, who pioneered the field of human retrovirology, and has made several scientific breakthroughs, including the co-discovery of HIV as the cause of AIDS. With this professorship, the E-Nnovations matching funds program strengthens the school’s research and development capabilities as a leader in vaccine development bringing life-saving treatments to patients around the globe.

“Ensuring that we can continue our research competitiveness by supporting new discoveries and vital care and treatment protocols in the areas of HIV/AIDS and other virally-linked diseases, as well as vaccine development, is a vital part of the School's Research Endowment Plan,” said Dr. Gallo, who is also the Homer & Martha Gudelsky Distinguished Professor of Medicine, and Director of UM SOM’s Institute of Human Virology (IHV). “In addition, the generous donations and matching funds provided through the E-Nnovation program will help IHV attract the best and the brightest medical virologists from around the world.”  

UM SOM will also use state matching funds to create an Endowed Distinguished Professorship in Entrepreneurial Surgical Science, established by a group of donors, including Thomas and Alice-Marie Hales, Hamish and Christine Osborne, The Peter and Georgia Angelos Foundation, and The Abell Foundation. The goal of the professorship is to seed a unique program that quickens the pace of developing feasible bioengineered solutions, and to increase creation of innovative medical technology and commercialization to help critically-ill people. The endowment will leverage the recruitment of a senior biomedical engineer to become the Endowed Professor in Entrepreneurial Surgical Science in the UM SOM Department of Surgery. 

“This professorship is an important part of the Department of Surgery’s plan to develop innovative surgical research programs that are ideally positioned for investment, translation and commercialization,” said Stephen T. Bartlett, MD, who is the Peter Angelos Distinguished Professor and Chairman of the Department of Surgery, as well as Executive Vice President and Surgeon-in-Chief of the University of Maryland Medical System.  

“Discoveries in critical fields including bio-designed organs, transplant tolerance, xenotransplantation, stem cell therapy and pleural and peritoneal cancers are waiting to be transformed into biomedical innovation that will revolutionize patient retreatment and improve patient outcomes.”

Ultimately, the goal is to replicate other successful startups funded by the Maryland Technology Development Corp. (TEDCO) and led by UM SOM surgeons. The creation of  Harpoon Medical, Inc., for example, co-founded in 2013 by James Gammie, MD, Professor of Surgery and Chief of the Division of Cardiac Surgery.  Harpoon’s licensed technology centers on an image-guided cardiac surgical tool inserted via a small incision between the ribs. Surgery and Executive Director of the UM SOM Program in Lung Healing, developed the first wearable “out-of-hospital “artificial lung system. UM Ventures and Breethe, Inc. announced in last year that Breethe, an early-stage, Baltimore-based medical device company, had obtained exclusive rights to University of Maryland, Baltimore intellectual property for the development of a wearable, portable blood pump oxygenator that will function as an artificial lung system for patients suffering from respiratory failure and cardiopulmonary collapse. 

The artificial lung will be the very first device in the field and will be tested first in humans at the University of Maryland Medical Center by UM SOM investigators. 

According to Brian J. DeFilippis, UM SOM Associate Dean for Development, the endowed professorships further enhance the school’s efforts to grow its research portfolio, provide a positive impact on the City of Baltimore and the State of Maryland, and engage prospective donors with an ideal opportunity for philanthropy. 

“This program presents a unique and outstanding benefit to our donors by offering the potential to magnify the impact of their philanthropy, to advance science and medicine and to propel the School of Medicine forward as a research powerhouse, said Mr. DeFilippis. “It is imperative that we capitalize on this incentive and grow the number of endowed professorships for our medical school.” 

About the University of Maryland School of Medicine 

The University of Maryland School of Maryland, chartered in 1807 as the first public medical school in the United States, continues today as a leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland, and is an integral part of the 12-campus University System of Maryland. Located on the University of Maryland’s Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists, plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S., with top-tier faculty and programs in vaccine development, cancer, brain science, surgery and transplantation, trauma and emergency medicine, and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the U.S., but also has a global presence, with research and treatment facilities in more than 30 countries around the world. http://medschool.umaryland.edu/

Contact

Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559

Contact Media Relations
(410) 706-5260

Related stories

    Friday, April 02, 2021

    Baltimore Sun: Q&A with Dr. Robert Gallo: ‘The world has to be linked to fight a pandemic’

    Robert Gallo, the eminent virologist best known as co-discoverer of the AIDS virus, says the world needs a system to confront viral disease that’s free of politics and primed to quickly warn nations about new threats as if “the bad Martians are coming.” The uneven and politicized response to the coronavirus pandemic, with a worldwide toll approaching 3 million, including 553,000 deaths in the United States, proves Gallo’s point.


    Thursday, February 18, 2021

    The Science Advisory Board: The next generation of COVID-19 vaccines: Gallo on next steps

    With emergency authorizations for several COVID-19 vaccines under our belt, the question remains if these vaccines will be enough to carry us through the end of the pandemic. Experts agree that there will likely need to be additional vaccines to achieve full recovery. In this two-part series, we discuss what a next-generation COVID-19 vaccine might look like, and which candidates are in the running for authorizations.


    Friday, February 12, 2021

    The Washington Post: Scientists said claims about China creating the coronavirus were misleading. They went viral anyway.

    The spread of the unverified assertions by Chinese scholar Li-Meng Yan, widely dismissed as “flawed,” show how vulnerable scientific sites are to misuse and misunderstanding.


    Friday, February 12, 2021

    China CDC Weekly: Commentary by Dr. Robert C. Gallo

    The Great Coronavirus Pandemic of 2019−2021: the Future and the Requirement for China-America Cooperation - Over the past century, the great pandemics and most epidemics (defined as virus presence and disease induction presenting more than the expected number of infections in a population) were caused by the sudden outbreak of an RNA virus such as the pandemics of influenza, polio, and HIV/AIDS and the epidemics of influenza, Ebola, Dengue, Zika, West Nile, severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and Chikungunya.


    Friday, December 11, 2020

    Bloomberg TV Asia: Dr. Robert Gallo on COVID-19 Vaccines

    Dr. Robert Gallo, co-founder and international scientific advisor of the Global Virus Network and the co-founder and director of the Institute of Human Virology at the University of Maryland School of Medicine, discusses the rollout of the Covid-19 vaccines. The first Covid-19 vaccine expected to be deployed in the U.S. won the backing of a panel of government advisers, a step that will likely help clear the way for emergency authorization by the Food and Drug Administration. Gallo, who co-discovered HIV as the cause of AIDS in 1984, speaks with Haidi Stroud-Watts and Shery Ahn on "Bloomberg Daybreak: Australia." (Source: Bloomberg)


    Wednesday, November 11, 2020

    Dr. Robert Gallo on Bloomberg Asia on COVID Vaccine Prospects

    Dr. Robert C. Gallo, The Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute of Human Virology at the University of Maryland School of Medicine and co-founder and international scientific advisor of the Global Virus Network, discusses the timeline and safety of Covid-19 vaccine trials. He speaks with Shery Ahn and Haidi Stroud-Watts on "Bloomberg Daybreak: Asia".


    Sunday, November 01, 2020

    The Scientist: How Some Vaccines Protect Against More than Their Targets

    As researchers test existing vaccines for nonspecific protection against COVID-19, immunologists are working to understand how some inoculations protect against pathogens they weren’t designed to fend off.


    Friday, August 28, 2020

    WYPR: Could Polio Vaccine Corral Covid-19?

    A safe, effective vaccine against Covid-19 could resurrect jobs, send kids back to classrooms--change our lives. But how safe and effective? And how quickly can we have it? Dr. Robert Gallo, the AIDS-research pioneer now leading virus science at the Institute of Human Virology at the University of Maryland School of Medicine and the Global Virus Network, argues we could get much of the benefit by inoculating people with an old, very cheap drug -- the oral Polio vaccine developed seven decades ago. Gallo contends it would trigger our ‘innate immunity’-- the body’s emergency response when a threat shows up.


    Monday, August 03, 2020

    Eureka, Charles River Laboratories: Could the Oral Polio Vaccine be Used to Prevent COVID-19?

    Virologist Robert Gallo, MD, has had a long and storied career in academic and government research. He is the Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology (IHV) at the University of Maryland School of Medicine and co-founder and international scientific adviser of the Global Virus Network. Despite his deep roots in HIV, Dr. Gallo’s current focus is, not surprisingly, COVID-19, which emerged in China last year and within four months morphed into a full-blown pandemic. As usual, Dr. Gallo’s research strategy has raised eyebrows. Unlike the antibody and RNA vaccines that are all the rage in COVID-19 science, Gallo is putting his energies behind repurposing the oral polio virus vaccine developed in the 1950s by Albert Sabin.


    Friday, July 31, 2020

    RollingStone-Useful Idiots: Dr. Robert Gallo on a COVID-19 Vaccine

    Dr. Robert Gallo, director of the Institute for Human Virology at the University of Maryland School of Medicine, joins the show to give his take on the prospects for an effective COVID-19 vaccine. Gallo is skeptical of the approach many organizations are taking with antibody vaccines, citing the similarly low efficacy those treatments had with HIV due to the low durability of the antibodies. Dr. Gallo’s research is mainly related to Oral Polio Vaccine, which he thinks needs to be tested more in regard to innate immunity.


    Friday, July 24, 2020

    A Statement from the Leadership of the Institute of Human Virology and the Global Virus Network on the Passing of Renowned Chinese Virologist Yi Zeng

    The IHV at the University of Maryland School of Medicine and the Global Virus Network (GVN), a coalition comprised of the world’s preeminent human and animal virologists from 55 Centers of Excellence and 10 Affiliates in 32 countries, collectively mourns the passing of Professor Yi Zeng, MD, Academician of the Chinese Academy of Sciences, former President of the Chinese Academy of the Preventive Medicine and former Dean of the College of Life Science and Bioengineering at Beijing University of Technology.


    Monday, July 20, 2020

    NPR: Early Oxford-AstraZeneca Coronavirus Vaccine Data 'Encouraging,' Scientists Say

    Dr. Robert Gallo is quoted about an experimental vaccine candidate being developed by AstraZeneca and Oxford University to protect against COVID-19 that triggered an immune response against the coronavirus and appeared to be safe.


    Tuesday, July 07, 2020

    Courthouse News Service: Global Progress on Ending HIV/AIDS Derailed by Covid-19

    A United Nations program aimed at eliminating HIV/AIDS released a report Monday showing that the global response to the epidemic has fallen far short of goals set for 2020, in large part due to the coronavirus pandemic.


    Monday, July 06, 2020

    Sputnik Radio: What If There Is No Vaccine for COVID-19?

    On today's episode of Loud & Clear, Brian Becker and John Kiriakou are joined by Robert Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor in Medicine, co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine and co-founder and international scientific adviser of the Global Virus Network. What would you think if someone told you that we already have a vaccine that at least helps fight Covid-19? That may already be the case. Two American scientists, Dr. Robert Gallo and Dr. Konstantin Chumakov, are positing that decades-old live vaccines for things like polio and tuberculosis strengthen the immune system’s first line of defense a more general way to fight infection. And the history books show us that that sometimes translates into at least some cross-protection against completely different viruses.


    Friday, July 03, 2020

    KUSI San Diego News: Dr. Robert Gallo suggests an oral polio vaccine could help fight coronavirus

    Dr. Robert Gallo from the Institute of Human Virology at the University of Maryland School of Medicine and Global Virus Network wrote an op-ed in the Wall Street Journal earlier this week. The opinion piece stated that OPV, oral polio vaccine, could be a cheap and effective way to fight coronavirus. Dr. Gallo discussed his opinion piece on Good Morning San Diego.


    Thursday, July 02, 2020

    13D Global Strategy & Research Report

    COVID-19 outbreaks are multiplying and immunity may be short-lived. Could existing “live” vaccines, which stimulate innate immunity, outshine vaccines targeting the “spike” protein?


    Thursday, June 25, 2020

    The New York Times: Dr. Robert Gallo: The Case for a Stopgap Vaccine

    In a letter to the editor to The New York Times entitled, "Dr. Robert Gallo: The Case for a Stopgap Vaccine," the noted virologist and head of the IHV says a polio vaccine may be an ideal solution until we find a Covid-specific vaccine.


    Wednesday, June 24, 2020

    The New York Times: Decades-Old Soviet Studies Hint at Coronavirus Strategy

    The New York Times: Decades-Old Soviet Studies Hint at Coronavirus Strategy: A married pair of virologists in Moscow tested a vaccine on their own children in the 1950s. Now, a side effect they found is sparking new hope for a defense against the coronavirus.


    Friday, June 12, 2020

    The Washington Post: We shouldn’t care who wins the vaccine ‘race’

    Dr. Robert Gallo writes a Letter to the Editor to The Washington Post entitled, “We shouldn’t care who wins the vaccine ‘race’,” regarding their June 4 front-page article “Cold War echoes in race for vaccine,” about the “race” among nations, notably the United States, China, and Russia and other European nations for development of a vaccine against the novel coronavirus.


    Friday, June 12, 2020

    CNN Health: An Existing Polio Vaccine Could Help Protect Against Coronavirus, Top Experts Say

    CNN: There is plenty of evidence that existing inoculations such as polio vaccines protect children against a wide range of infections and it's worth trying them out against the new coronavirus, a team of experts wrote in Science magazine Thursday.


    Thursday, June 11, 2020

    NBC News: Polio Vaccine Could Give Temporary Protection Against COVID-19, Scientists Hope

    NBC News: As the world waits for a coronavirus vaccine, some scientists are proposing that existing vaccines could give the body’s immune system a much-needed temporary boost to stave off infection. It’s still unclear whether such an approach would work, and some experts are skeptical. Others — including researchers in Israel, the Netherlands and Australia — are already investigating whether a tuberculosis vaccine could help jump-start the immune system and make COVID-19 less deadly, though the World Health Organization strongly advises against using that vaccine until it’s proven effective against the coronavirus.


    Monday, May 11, 2020

    BBC Global News Interviews Dr. Robert Gallo on Oral Polio Vaccine for SARS-CoV-2 and More

    Dr. Robert Gallo appeared on BBC World News with Matthew Amroliwala for a one-on-one, lengthy interview during their Coronavirus Explained segment.


    Saturday, May 09, 2020

    Dr. Robert Gallo Discuss COVID-19 Research on Aljazeera News

    Aljazeera discusses the status of therapy, testing and vaccine research on SARS-CoV-2/COVID-19 with Dr. Robert Gallo.


    Thursday, May 07, 2020

    The Disappointing Truth About Antibody Testing: There’s still a lot we don’t know about COVID-19

    Dr. Robert Gallo discusses the status of COVID-19 antibody test with Vox's The Verge


    Wednesday, May 06, 2020

    The Coronavirus Appears to have Mutated. What Does that Mean for Contagiousness?

    While small mutations in the virus's genetic code are evident, it's unclear what these changes mean for people, if anything at all.


    Saturday, May 02, 2020

    IHV's Dr. Robert Gallo on FOX's Full Court Press with Greta Van Susteren

    Overtime: Dr. Robert Gallo talks coronavirus treatments and antibody testing.


    Saturday, May 02, 2020

    Dr. Robert Gallo on iHeart Radio to Discuss COVID-19

    Ryan Gorman hosts an iHeartRadio nationwide special featuring experts on COVID-19-related issues, including the co-founder and director of the Institute Human Virology at the University of Maryland School of Medicine, the senior vice president for U.S. Programs & Advocacy at Save the Children, and the managing editor of the Military Times. Topics range from a discussion about why some people infected by the coronavirus are asymptomatic, while others face severe reactions and even death, to assistance for impoverished children, and a breakdown of the impact the virus is having on the U.S. military and veterans.


    Friday, May 01, 2020

    Could an Oral Polio Vaccine Stop the Coronavirus Pandemic?

    A YouTube video by the American Chemical Society and produced by PBS.


    Wednesday, April 22, 2020

    Dr. Robert Gallo Featured on National Geographic’s “Jane Goodall: The Hope” on 50th Anniversary of Earth Day

    For the 50th anniversary of Earth Day on April 22, 2020, the National Geographic channel will broadcast back-to-back premieres of Photo Ark: Rarest Creatures and Jane Goodall: The Hope.


    Tuesday, December 04, 2018

    Institute of Human Virology Researchers Discover That a Bacterial Protein Promotes Cancer

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) announced today the discovery that DnaK, a protein of the bacterium mycoplasma, interferes with the mycoplasma-infected cell’s ability to respond to and repair DNA damage, a known origin of cancer.


    Monday, December 03, 2018

    Institute of Human Virology Names Dr. Man Charurat as Director of the Center for International Health, Education, and Biosecurity

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine today announced the appointment of Man E. Charurat, PhD, MHS, Professor of Medicine and Director of the Division of Epidemiology and Prevention at the IHV as the Director of IHV’s Center for International Health, Education, and Biosecurity (CIHEB). Dr. Charurat will replace Deus Bazira, DrPH, MPH, MBA. The announcement was made by Robert C. Gallo, MD, The Homer & Martha Gudelsky Distinguished Professor in Medicine, Co-Founder and Director of the IHV, and Co-Founder and Director of the Global Virus Network (GVN).


    Tuesday, October 23, 2018

    Institute of Human Virology Hosts 20th Annual International Meeting of Top Medical Virus Researchers in Baltimore, Maryland

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine yesterday commenced IHV’s 20th Annual International Meeting, to be held through Thursday, October, 25 at the Four Seasons Hotel in Baltimore, Maryland. This year, among other viral and cancer related topics, the meeting is holding special sessions on the 40th anniversary of the first human retrovirus, Human T cell Leukemia Virus (HTLV), and the 15th anniversary of the President’s Emergency Plan for AIDS Relief (PEPFAR). IHV’s Annual International Meeting attracts hundreds of elite scientists who descend upon Baltimore to share ideas and inspire medical virus research collaborations.


    Wednesday, September 19, 2018

    Institute of Human Virology (IHV) Awarded $12M to Combat Opioid Epidemic Through Clinical Research Trials

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine will lead a $12 million dollar project to improve the morbidity and mortality of people with opioid use disorder (OUD). Utilizing a novel compound, IHV researches will implement a series of investigations, entitled SEARCH, to evaluate the underlying mechanisms of craving reduction as a strategy to prevent opioid misuse, dependence, and relapse. The grant is awarded through the National Institutes of Health’s (NIH) Helping to End Addiction Long-term (HEAL) Initiative, made possible through groundbreaking funding from the U.S. Congress.


    Tuesday, December 12, 2017

    A Statement from the Leadership of the Institute of Human Virology on the Passing of Stewart Greenebaum

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine mourns the passing of Stewart Greenebaum, a lifelong Baltimore resident, former president of Greenebaum and Rose Associates, and past chairman of the IHV Board of Advisors, as well as a guiding force in the establishment of the IHV at the University of Maryland, Baltimore.


    Wednesday, November 29, 2017

    To Mark World AIDS Day, Institute of Human Virology Releases Video on Dr. Robert Gallo

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UMSOM) released a video on Dr. Robert Gallo, a trailblazer in HIV research, in advance of World AIDS Day, December 1. While many know Dr. Gallo for his pioneering work in AIDS research, the short video focuses on Dr. Gallo’s life and legacy in its entirety, including his pioneering discovery of human retroviruses.


    Tuesday, October 25, 2016

    "A Call to End HIV/AIDS in America" IHV Director Dr. Robert Gallo's Op-Ed in the Huffington Post

    As the new Administration is presented with great challenges facing the United States, one will be a longtime foe, the U.S. HIV/AIDS epidemic. Since President Barack Obama was elected in 2008, I have publicly called on our country’s leaders to utilize the largest global health initiative in history - the President’s Emergency Plan for AIDS Relief (PEPFAR) - as a model to address the U.S. epidemic.


    Monday, August 22, 2016

    Institute of Human Virology (IHV) Awarded $14.4M for HIV Vaccine Research

    The Institute of Human Virology (IHV) announced a $14.4M grant from NIAID to advance HIV vaccine research to solve a major challenge: produce long-lasting antibodies to protect against HIV infection.


    Tuesday, September 29, 2015

    Institute of Human Virology Hosts International Meeting of Prominent AIDS Researchers

    The Institute of Human Virology (IHV) at the University of Maryland School of Medicine is hosting IHV’s 17th Annual International Meeting Sunday, September 27 through Wednesday, September 30 at the Baltimore Marriott Waterfront Hotel in Baltimore, Maryland.